Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
<i>Purpose</i>: Compare pancreatic ductal adenocarcinoma (PDAC), preclinical models, by their transcriptome and drug response landscapes to evaluate their complementarity. <i>Experimental Design</i>: Three paired PDAC preclinical models—patient-derived xenografts (PDX), xenog...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/10/2473 |